Results 221 to 230 of about 278,879 (377)

Humanin improves bone health in a glucocorticoid-treated mouse model of Duchenne muscular dystrophy. [PDF]

Biochem Biophys Rep
Cedervall T, Jude B, von Walden F, Velentza L, Lanner JT, Sejersen T, Zaman F, Sävendahl L.   +7 more
europepmc   +1 more source

Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study. [PDF]

BMJ Open Diabetes Res Care
Chen AX, Radhakutty A, Thompson C, Burt MG.   +3 more
europepmc   +1 more source

Effects of Phenobarbital and Prednisolone on Neurological Signs of Canine Distemper [PDF]

Ali Asghar Sarchahi, Mohammad Arbabi, Hadi Mohebalian   +2 more
openalex   +1 more source

Clinical features and incidence of central nervous system involvement in patients with adult T‐cell leukaemia/lymphoma

British Journal of Haematology, EarlyView.
Summary Central nervous system (CNS) involvement is a known complication of adult T‐cell leukaemia/lymphoma (ATL), but its clinical characteristics and incidence still remain unclear. This study characterized the clinical features and incidence of CNS involvement in patients with ATL (CNS‐ATL).
Takuya Ueno, Makoto Yoshimitsu, Momone Sameshima, Taichi Nagano, Rika Akahoshi, Yusetsu Takeshita, Aya Shodai, Kodai Shima, Naosuke Arima, Yuhei Kamada, Daisuke Nakamura, Kenji Ishitsuka   +11 more
wiley   +1 more source

The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working Group. [PDF]

Clin Kidney J
Frangou E, Kronbichler A, Steiger S, Bruchfeld A, Caravaca-Fontán F, Mirioglu S, Moran S, Quintana LF, Stevens KI, Teng YKO, Floege J, Vivarelli M.   +11 more
europepmc   +1 more source

Pharmacokinetics of Prednisolone (PSL) during PSL Treatment

, 1986
Eiichi Goshima, Keigo Yasuda, Yoshiyuki FUWA, Kayoko Adachi, Yoshiaki Minamori, Hiroshi Murase, Masanori A. Murayama, Noriyoshi Yamakita, Kiyoshi Miura   +8 more
openalex   +2 more sources

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population‐based study

BJU International, EarlyView.
Objective To estimate risk of prostate‐specific antigen (PSA) relapse after radical radiotherapy (RT) for prostate cancer (PCa), and risk of PCa death after relapse according to Gleason score and time to relapse. Patients and Methods Men in the National Prostate Cancer Register of Sweden who underwent primary radical RT in 2007–2024 were followed until
Paolo Zaurito, Hans Garmo, Rolf Gedeborg, Mats Alhberg, Stefan Carlsson, Camilla Thellenberg, David Robinson, Pär Stattin, Marcus Westerberg   +8 more
wiley   +1 more source

The Evolving Experience and Outcomes of Pediatric Kidney Transplant in Abu Dhabi, UAE (2010-2024). [PDF]

Int J Nephrol
Beyyumi E, Al Dhaheri W, Ahmad N, Zaman MB, Khasawneh EA.   +4 more
europepmc   +1 more source

Fourteen-day rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP-14): use it right or do not use it at all [PDF]

, 2012
Carsten Zwick, Michael Pfreundschuh
openalex   +1 more source

Impact of Achieving Progression‐Free Survival 24 on Subsequent Overall Survival in Diffuse Large B‐Cell Lymphoma Patients

Cancer Science, EarlyView.
The OS for patients after achieving PFS24 or PFS60 was not markedly different from that of the age‐, sex‐, and calendar period‐matched Japanese general population (PFS24: standardized mortality ratio [SMR] 1.29, 95% confidence interval [CI] 0.72–2.12, p = 0.39; PFS60: SMR 1.43, 95% CI 0.47–3.33, p = 0.55).
Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa, Ryunosuke Machida, Tomotaka Suzuki, Kazuyuki Shimada, Tsutomu Kobayashi, Ken Ohmachi, Tomohiro Kinoshita, Kiyoshi Ando, Dai Maruyama, Hirokazu Nagai   +11 more
wiley   +1 more source